###begin article-title 0
###xml 68 70 64 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
Caveolae Contribute to the Apoptosis Resistance Induced by the alpha1A-Adrenoceptor in Androgen-Independent Prostate Cancer Cells
###end article-title 0
###begin p 1
Conceived and designed the experiments: MK CEB FG. Performed the experiments: MK AA ED NJ GB. Analyzed the data: MK CEB FG AA PM ED NJ. Contributed reagents/materials/analysis tools: PD AA ED NJ CL BM. Wrote the paper: MK FG. Participated in the coordination of the study and manuscript revision: CS NP. Read and approved the final manuscript: CS CEB FG PD PM ED CL GB NP. Participated in discussion of the results: PM. Critically revised the manuscript: PM CM. Participated in revising the new version of the manuscript: GB.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 365 367 361 363 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
During androgen ablation prostate cancer cells' growth and survival become independent of normal regulatory mechanisms. These androgen-independent cells acquire the remarkable ability to adapt to the surrounding microenvironment whose factors, such as neurotransmitters, influence their survival. Although findings are becoming evident about the expression of alpha1A-adrenoceptors in prostate cancer epithelial cells, their exact functional role in androgen-independent cells has yet to be established. Previous work has demonstrated that membrane lipid rafts associated with key signalling proteins mediate growth and survival signalling pathways in prostate cancer cells.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 54 56 50 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 310 312 302 304 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 444 446 432 434 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 648 650 632 634 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
In order to analyze the membrane topology of the alpha1A-adrenoceptor we explored its presence by a biochemical approach in purified detergent resistant membrane fractions of the androgen-independent prostate cancer cell line DU145. Electron microscopy observations demonstrated the colocalisation of the alpha1A-adrenoceptor with caveolin-1, the major protein component of caveolae. In addition, we showed that agonist stimulation of the alpha1A-adrenoceptor induced resistance to thapsigargin-induced apoptosis and that caveolin-1 was necessary for this process. Further, immunohistofluorescence revealed the relation between high levels of alpha1A-adrenoceptor and caveolin-1 expression with advanced stage prostate cancer. We also show by immunoblotting that the TG-induced apoptosis resistance described in DU145 cells is mediated by extracellular signal-regulated kinases (ERK).
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 36 38 32 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 110 113 106 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
In conclusion, we propose that alpha1A-adrenoceptor stimulation in androgen-independent prostate cancer cells via caveolae constitutes one of the mechanisms contributing to their protection from TG-induced apoptosis.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 130 133 130 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Parkin1">[1]</xref>
###xml 551 554 551 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Arnold1">[2]</xref>
###xml 788 791 788 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-McKenzie1">[3]</xref>
###xml 1168 1169 1164 1165 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1190 1191 1182 1183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1206 1208 1194 1196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1331 1334 1319 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Higgins1">[4]</xref>
###xml 1336 1339 1324 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Chapple1">[5]</xref>
###xml 1350 1352 1334 1336 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1508 1511 1492 1495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Neer1">[6]</xref>
###xml 61 64 <span type="species:ncbi:9606">men</span>
Prostate cancer is one of the most common forms of cancer in men and the second cause of cancer death in industrialized countries [1]. Various factors such as androgens and growth factors regulate epithelial cell proliferation and apoptosis in the normal prostate and early-stage prostate cancer (PCa). Androgen ablation is currently the leading therapy used to block the growth of androgen-dependent cancer cells. However PCa cells' proliferation and survival often become independent of regulatory mechanisms leading to a hormone-refractory disease [2] for which there is currently no successful therapy. Androgen-independent PCa cells have the remarkable ability to adapt to the surrounding microenvironment whose influence on intracellular survival pathways remains subject to debate [3]. Indeed, PCa cells are in contact with various factors such as hormones, growth factors and neurotransmitters which are thought to influence the physiology of these cells. Among others, interest has been shown for the endogenous catecholamines norepinephrine and epinephrine. In fact, the subepithelial stroma of the prostate is particularly rich in autonomic nerves and alpha1-adrenoceptors (alpha1-AR). The alpha1A-AR subtype, in particular, is found in smooth muscle cells but its expression has also been described in epithelial cells [4], [5]. The alpha1A-AR is a member of the superfamily of G-protein coupled receptors (GPCR) mediating actions of the previously mentioned catecholamines in a variety of cells [6].
###end p 9
###begin p 10
###xml 5 6 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 103 106 99 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Raghavan1">[7]</xref>
###xml 181 182 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 226 229 218 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Andersson1">[8]</xref>
###xml 309 310 297 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 601 604 589 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Kyprianou1">[9]</xref>
###xml 606 610 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Anglin1">[10]</xref>
###xml 612 616 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Chiang1">[11]</xref>
###xml 813 815 797 799 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 859 863 843 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Thebault1">[12]</xref>
###xml 865 869 849 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Thebault2">[13]</xref>
###xml 933 935 913 915 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 667 672 <span type="species:ncbi:9606">human</span>
alpha1-AR antagonists are already used for the clinical treatment of benign prostate hyperplasia (BPH) [7], where their therapeutic benefit is attributed to a direct action on alpha1-AR present in prostate smooth muscle cells [8]. However, several studies have provided evidence on additional effects of alpha1-AR antagonists such as doxazosin on long-term BPH treatment. These agents have been demonstrated to inhibit prostate growth by inducing apoptosis in stromal and epithelial cells and are emerging as potential therapeutic regimens for the prevention and treatment of androgen-independent PCa [9], [10], [11]. In addition, previous studies from co-workers on human prostate cancer epithelial (hPCE) cells and the androgen-dependent prostate cancer cell line LNCaP showed that phenylephrine (PHE), an alpha1A-AR agonist, stimulates their proliferation [12], [13]. Despite these promising findings, the functional role of alpha1A-AR in androgen-independent PCa cells has yet to be established.
###end p 10
###begin p 11
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Chini1">[14]</xref>
###xml 215 216 211 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 354 358 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Fujita1">[15]</xref>
###xml 360 364 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Morris1">[16]</xref>
###xml 618 622 614 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Smart1">[17]</xref>
###xml 732 736 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Williams1">[18]</xref>
###xml 738 742 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-vanHelmond1">[19]</xref>
###xml 853 857 849 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Yang1">[20]</xref>
###xml 1046 1050 1042 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Nasu1">[21]</xref>
###xml 1218 1222 1214 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Thompson1">[22]</xref>
It has been described that the signalling and trafficking of several GPCR are regulated by specialized plasma membrane domains known as lipid rafts [14]. Moreover, recent data on cardiomyocytes have shown that alpha1-AR as well as the molecules involved in its signal transduction pathway are accumulated in caveolae, a subclass of membrane microdomains [15], [16]. Caveolae are 50-100 nm flask-shaped plasma membrane invaginations, characterized on one hand by high contents of cholesterol and glycosphingolipids and on the other hand by the presence of caveolin-1 (cav-1), the major constitutive protein of 20-25 kD [17]. Interestingly, cav-1 has been associated with many diseases such as atherosclerosis and Alzheimer's disease [18], [19]. Regarding its role in cancer, it has been established that PCa is associated with increased cav-1 expression [20]. In fact, this protein has been identified as a marker associated with PCa progression and hormone-refractory disease, playing a determinant role in the androgen-independence of PCa cells [21]. By its association with specific receptors and enzymes on the plasma membrane, cav-1 can be a direct mediator of survival, growth and metastasis signals in PCa cells [22].
###end p 11
###begin p 12
###xml 146 148 142 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 274 276 266 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 323 325 311 313 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 343 346 331 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
To date, not much is known about the mechanisms underlying neurotransmitters involvement in the survival of PCa cells, let-alone the role of alpha1A-AR in androgen-independent epithelial cells and PCa progression. In this regard, it is tempting to link the presence of alpha1A-AR and cav-1 and to hypothesize that the alpha1A-AR could mediate via caveolae its functional effects on growth or survival of advanced stage PCa cells.
###end p 12
###begin p 13
###xml 72 74 68 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 155 157 147 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 293 295 281 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 756 758 740 742 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 828 830 808 810 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
The objective of our work was therefore to explore the role of the alpha1A-AR in androgen-independent PCa cells. Here, we investigate the presence of alpha1A-AR in caveolae of DU145 cells, an androgen-independent PCa cell line derived from brain metastasis. We analyze the consequence of alpha1A-AR stimulation by PHE on the receptor and cav-1 membrane distribution as well as its effect on the lipid composition of membrane raft fractions purified from DU145 cells. Furthermore, we describe the effect of PHE in the apoptosis resistance of these cells through activation of ERK and our results strongly imply the involvement of caveolae in this signalling pathway. Finally, by immunohistofluorescence and RT-PCR, we observe a positive correlation of alpha1A-AR and cav-1 expression and advanced stage PCa. The presence of alpha1A-AR-rich caveolae could therefore contribute to the generalized apoptosis resistance characterizing androgen-independent prostatic tissue.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Cell culture
###end title 15
###begin p 16
###xml 421 422 415 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 25 30 <span type="species:ncbi:9606">human</span>
The androgen-independent human prostate cancer cell line DU145, obtained from the American Type Culture Collection, was maintained in culture in RPMI 1640 medium (Life Technologies, Inc) supplemented with 10% (v/v) FCS (Seromed, Poly-Labo, Strasbourg, France), 5 mM L-glutamine and 2 mM kanamycin (Sigma). Cells were routinely grown in 50 ml flasks (Nunc, PolyLabo, Strasbourg, France) at 37degreesC in a humidified 5% CO2-95% air atmosphere. These cells constitute a suitable model for brain metastatic cancer cells present in hormone-refractory prostate cancer.
###end p 16
###begin title 17
Cell transfections and generation of cav-1 knock-down DU145 cell line
###end title 17
###begin p 18
###xml 37 39 33 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
Two ready-to-use siRNAs against alpha1A-AR (siADR1A, Eurogentec) were transiently transfected (50 nM) with HiPerfect Transfection Reagent (Qiagen) in DU145 cells. Control siRNA (siCTL) experiments were performed by transfecting siRNA against Luciferase.
###end p 18
###begin p 19
###xml 23 48 23 48 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CUUACGCUGAGUACUUCGA-3&#8242;</named-content>
###xml 70 94 70 94 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGGAAAGAUGCAGAGGA-3&#8242;</named-content>
###xml 99 123 99 123 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-UUCCUCUGCAUCUUUCCU-3&#8242;</named-content>
###xml 145 169 145 169 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCGUCUACGUGGUGGCCA-3&#8242;</named-content>
siLuciferase (siCTL) : 5'-CUUACGCUGAGUACUUCGA-3'. siADR1A-1 (mix of): 5'-CAGGAAAGAUGCAGAGGA-3' and 5'-UUCCUCUGCAUCUUUCCU-3'. siADR1A-2 (mix of): 5'-GCGUCUACGUGGUGGCCA-3' and 5'-UUGGCCACCACGUAGACG-3'.
###end p 19
###begin p 20
###xml 141 162 141 162 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTGGAATAAGTTCAAATTCTT</named-content>
###xml 346 347 346 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
Stable cell lines were obtained by transfecting DU145 cells with a Psuper vector encoding short hairpin RNA (shRNA) against cav-1 (sequence: CTGGAATAAGTTCAAATTCTT 2121 3'utr) (DUshcav-1) (or empty Psuper vector for control cell line, DUshCTL) using Nucleofector, as recommended by the manufacturer (Amaxa GmbH, Koln, Germany). We transfected 2x106 trypsin-treated DU145 cells with 3 microg of vector and then used the transfected cells to seed a 24 well plate (Nunc) at very low density. Clones underexpressing cav-1 were selected on the basis of their antibiotic resistance to puromycine and validated by Western Blot.
###end p 20
###begin title 21
Antibodies and Reagents
###end title 21
###begin p 22
###xml 118 120 114 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 101 107 <span type="species:ncbi:9986">rabbit</span>
###xml 170 176 <span type="species:ncbi:9986">rabbit</span>
###xml 228 233 <span type="species:ncbi:10090">mouse</span>
###xml 290 295 <span type="species:ncbi:10090">mouse</span>
###xml 390 395 <span type="species:ncbi:10090">mouse</span>
###xml 463 469 <span type="species:ncbi:9986">rabbit</span>
###xml 506 511 <span type="species:ncbi:10090">mouse</span>
###xml 632 638 <span type="species:ncbi:9986">rabbit</span>
###xml 811 822 <span type="species:ncbi:3704">horseradish</span>
###xml 846 851 <span type="species:ncbi:10090">mouse</span>
###xml 860 866 <span type="species:ncbi:9986">rabbit</span>
Primary antibodies used for immunofluorescence (IF) microscopy and immunoblotting (IB) were: (1:100) rabbit anti-alpha1A adrenoceptor (Santa Cruz Biotechnology), (1:100) rabbit anti-caveolin-1 (Santa Cruz Biotechnology), (1:50) mouse anti-caveolin-1 (BD transduction Laboratories), (1:400) mouse anti-beta-actin (Sigma), (1:200) anti-calnexin (Chemicon, Millipore, Paris, France), (1:1000) mouse anti-cytokeratin 18 (Chemicon, Millipore, Paris, France), (1:1000) rabbit anti-PARP (Cell Signaling), (1:100) mouse anti-bax (6A7) (Santa Cruz Biotechnology) recognizing an exposed epitope of bax in the activated conformation, (1:1000) rabbit anti-procaspase 3 (UPSTATE), (1:1000) anti-phospho-p44/42 MAP Kinase and (1:1000) anti-p44/42 MAP Kinase (Cell Signaling). Secondary antibodies used for IB were: (1:10000) horseradish peroxidase-linked anti-mouse or anti-rabbit (Chemicon). For IF, we used (1:1000) Alexa Fluor(R) 488-labelled and (1:2000) 546-labelled secondary antibodies (Molecular Probes).
###end p 22
###begin p 23
###xml 310 311 294 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 322 323 306 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 335 336 319 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 344 345 328 329 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 347 348 331 332 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Cells were treated with 10 microM L-Phenylephrine Hydrochloride (PHE), 1 microM prazosin (PRA) and 10 microM PD98059 for three days (renewed every 24 h) and 10 microM Thapsigargin (TG) for 48 hours in RPMI medium. Short term PHE treatments were realized in a solution containing (mM): NaCl, 116; KCl, 5.6; CaCl2, 1.8; MgCl2, 1.2; NaHCO3, 5; NaH2PO4, 1; HEPES, 20; pH 7.3. All chemical products were provided by Sigma except TG (Alomone) and PD98059 (Calbiochem).
###end p 23
###begin title 24
Cell cycle analysis
###end title 24
###begin p 25
Cells were grown in three 60-mm dishes per condition and drugs were applied as described above. After treatments, cells were trypsinized, harvested and resuspended in 0.2 ml sterile PBS. 1 ml of cold 70% ethanol was added onto cell suspensions while vortexing. Samples were centrifuged, washed in sterile PBS and then incubated with ribonuclease (2 microg/ml) for 15 min. Propidium iodide (25 microg/ml final in PBS-triton X-100 0.1%) was then added and allowed to incubate for an additional 30 min. DNA content was measured by exciting propidium iodide at 488 nm and measuring the emission at 520 nm (FL3) using a flow cytometer (Beckman coulter Epics XL4-MCL with Expo32 acquisition). Experiments were repeated four times.
###end p 25
###begin title 26
Western Blot
###end title 26
###begin p 27
###xml 398 399 398 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 762 768 <span type="species:ncbi:9913">bovine</span>
###xml 1070 1081 <span type="species:ncbi:3704">horseradish</span>
###xml 1127 1132 <span type="species:ncbi:10090">mouse</span>
###xml 1141 1147 <span type="species:ncbi:9986">rabbit</span>
The cell culture medium was discarded and flasks were washed with iced PBS. Cellular proteins were then extracted using RIPA buffer [1% (v/v) Triton X-100, 1% (w/v) Na deoxycholate, 150 mM NaCl and 20 mM sodium or potassium phosphate, pH 7.2] with 5 mM EDTA and anti-proteases cocktail (P8340; Sigma) for 30 min on ice. After scraping, any insoluble material was removed by centrifugation at 30000xg for 10 min at 4 degreesC and the amount of protein was assessed by the BCA method (Pierce Chemical Company, Rockford, IL, U.S.A.). Equal amounts of proteins were subjected to SDS/PAGE (16% gels). Finally, the proteins were transferred on to nitrocellulose membranes using a semi-dry electro-blotter (Bio-Rad). After 1 h saturation in 5% non-fat milk (or 5% BSA (bovine serum albumin) only for anti-phospho-p44/42 MAPK), membranes were incubated overnight with diluted primary antibodies (see "Antibodies and Reagents"). The membranes were then washed (3x10 min) with a TNT buffer (15 mM Tris/HCl, pH 8, 140 mM NaCl and 0.05% Tween 20) and treated with the corresponding horseradish peroxidase-linked secondary antibodies (anti-mouse or anti-rabbit, Pierce), (1:10000) diluted in TNT/milk (or TNT/BSA) for 1 h at room temperature. After several washes in TNT buffer, the membranes were processed for chemiluminescent detection using the Super Signal West Dura chemiluminescent substrate (Pierce) according to the manufacturer's instructions. The membranes were finally exposed to X-Omat AR films (Eastman Kodak Company, Rochester, NY, U.S.A.). The intensity of the signals was evaluated by densitometry and semi-quantified using the ratio for each sample between the intensity of protein of interest divided by the actin or calnexin intensity. Each experiment was repeated at least twice.
###end p 27
###begin title 28
Isolation of Detergent Resistant Membranes (DRM) and Dot blot
###end title 28
###begin p 29
###xml 291 292 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 783 784 777 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1069 1070 1057 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Cells were rinsed, scrapped, centrifuged and the supernatant was removed. The pellet was resuspended with isolation buffer B (according to Axis-Shield S33 Application Sheet) and homogenized with a Dounce homogenizer (Kontes) of 15 microm pestle clearance then centrifuged for 10 min at 1000xg. The supernatant corresponding to crude lipid raft extract was isolated and 0.2% Triton X-100 was added. A discontinuous 5-step Optiprep(R) (Axis-Shield PoC AS) gradient was formed with buffer D (buffer B+1% Triton X-100) (w/v) in order to obtain 1.66 ml of 35%; 2.5 ml of 20%; 2.5 ml of 15%; 2.5 ml 10%; 0.83 ml of 5%. Crude lipid raft extract was made dense with sucrose (230 mg for 0.5 ml of lysate) and laid at the interface between gradients 35% and 20%. Ultracentrifugation at 165400xg for 4 h at 4degreesC in 50 Ti rotor (Beckman Coulter) was followed by collection from the bottom up of 1.1 ml fractions. 1.1 ml of 20% (v/v) TCA (Trichloroacetic Acid) was added to each fraction in order to precipitate proteins. Tubes kept on ice for 20 min were centrifuged at 10000xg at 4degreesC for 10 min. The precipitate was washed with methanol, centrifuged then re-suspended in 4% (v/v) SDS. Since samples were not highly concentrated in proteins and detection by classical western blot was difficult to obtain, samples were loaded on nitrocellulose membrane in a 96-well Dot-Blot unit according to the manufacturer's instructions (Bio-Rad). Briefly, the ten fractions were spotted onto nitrocellulose membrane in series. When dry, the membrane was incubated in blocking solution for 1 h (TNT/milk) then hybridized with the desired antibodies following classical IB procedure as described above (see "Western Blot"). Precautions were accordingly taken in keeping some important factors constant for the treated and non-treated conditions. The cell density used for the experiments was constant and when cold detergent extraction was carried out both the concentration of the detergent and the ratio of cell number/detergent concentration were the same. Each well was loaded with 25 microl from each fraction. This standardized method was repeated at least three times and was used to evaluate changes in the partitioning of a target molecule in DRM, avoiding false estimations when based on the relative amounts with regard to all other molecules present.
###end p 29
###begin title 30
Quantification of phosphatidylcholine (PC) and sphingomyelin (SM)
###end title 30
###begin p 31
###xml 62 66 62 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Folch1">[23]</xref>
###xml 377 381 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Becart1">[24]</xref>
Lipids were extracted according to the method of Folch et al. [23]. Dimyristoylphosphatidylcholine (DMPC Sigma), dimyristoylphosphatidylserine (DMPS Avanti Polar Lipids), lauroylsphingomyelin (LSM Avanti Polar Lipids) were used as internal standards. Phospholipid analysis was performed on a Hypersil Si 2x200 mm column (Agilent Technologies, Massy, France) following protocol [24]. Positive ESI-MS was performed on a MSD 1100 Mass Spectrometer (Agilent Technologies). The orifice voltage was set at 120 V, the capillary voltage at 3.5 kV, the drying gas (Nitrogen) flow at 8 l/min and scan range from m/z 400 to 950. Integrated peak were as from Extracted Ion Chromatograms (EIC) for m/z = 700 to 950 at the retention time (RT) of PC, PS, SM were divided by the EIC for m/z = 679 at the RT of DMPC, m/z = 681 at the RT of DMPS or m/z = 647 at the RT of LSM. Levels were determined by comparison of this ratio with a standard curve of known amounts of phosphatidylcholine and sphingomyelin.
###end p 31
###begin title 32
Quantification of Cholesterol
###end title 32
###begin p 33
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Abo1">[25]</xref>
Extraction and saponification were performed according to the previously described procedure [25] with some modifications. Quantification of cholesterol was performed using a HP6890 Gas Chromatograph equipped with an HP7683 Injector and a HP5973 Mass Selective Detector (Agilent Technologies). Chromatography was performed using a HP-5MS fused silica capillary column (30 mx0.25 mm inner diameter, 0.25 microm film thickness, Agilent Technologies). A selected ion-monitoring program was used for mass spectrometry. The ions used for analysis (m/z) were as follows: epicoprostanol, 370; cholesterol, 368. Calibration curves were obtained by analyzing standards prepared from authentic standards (Steraloids) and extracted with the method used for samples.
###end p 33
###begin p 34
The above quantification protocols for lipids and cholesterol were repeated three times for three individual experiments in non-treated (control) and treated DU145 cells with PHE for 10 min. As the amounts of lipids and cholesterol quantified in each fraction (ng/ml or microg/ml) varied slightly among experiments, results were normalised by determining mean values for the three experiments represented by the percentage of lipid and cholesterol in each fraction in control conditions compared to PHE-treated conditions.
###end p 34
###begin title 35
Plasma Membrane "Rip Off"
###end title 35
###begin p 36
###xml 46 50 46 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Lamaze1">[26]</xref>
###xml 135 139 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Tokuyasu1">[27]</xref>
###xml 454 460 <span type="species:ncbi:9793">donkey</span>
This method was based on a published protocol [26]. Cells were grown on glass coverslips. Formvar(R)-coated copper grids (according to [27]) were coated with polylysine. Coverslips were placed cell side down onto the grids and a slight pressure was exerted using a rubber bung then coverslips were turned over and the grids were carefully detached then fixed in 8% (v/v) PFA (paraformaldehyde). After washing in PBS and saturation in PBS/2.5 mM, glycine/donkey serum immunolabelling was carried out according to standard techniques, using primary antibodies followed by species-specific anti-IgG gold conjugates of 6 nm, 12 nm and 18 nm. Finally, grids were contrasted and prepared for observation on a Hitachi H-600 transmission electron microscope (magnification x20000) at 75 kV.
###end p 36
###begin title 37
Ultrastructural Microscopy
###end title 37
###begin p 38
For transmission electron microscopy, Cells were fixed in 2.5% glutaraldehyde prepared in 0.1 M cacodylate buffer and post-fixed in 1% osmium tetroxide in the same buffer. After acetonitril dehydration, the pellet was embedded in Epon. Serial thin sections (90 nm) were cut using a Reichert Ultracut E ultramicrotome and collected on 150 mesh hexagonal barred copper grids. After staining with 2% uranyl acetate prepared in 50% ethanol and incubation with a lead citrate solution, sections were observed on a Hitachi H-600 transmission electron microscope.
###end p 38
###begin title 39
Indirect Immunofluorescence
###end title 39
###begin p 40
###xml 468 472 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Gackiere1">[28]</xref>
###xml 29 34 <span type="species:ncbi:9606">human</span>
Resection BPH specimens from human prostate frozen in liquid nitrogen-cooled isopentane and kept in "Tissue-Tek(R)" at -80degreesC before 10 microm sections were prepared at -20degreesC with a cryostat, mounted on glass slides and proceeded to IF study. Normal and cancerous prostate tissues were supplied by tissue-array slides (SuperBioChips Laboratories), deparaffinized according to manufacturer's indications (Cliniscience) before preparation for IF according to [28]. Briefly, all slides were blocked during 30 min with PBS/1.2% (v/v) gelatin then incubated with desired primary antibodies for 1 h at 37degreesC then secondary antibodies (1 h, 37degreesC). Imaging was performed using Zeiss LSM 510 confocal head (Carl Zeiss) connected to a Zeiss Axiovert 200 M microscope with a x40 oil-immersion objective lens (numerical aperture 1.45). Slides were scanned using an argon ion laser and a helium/neon ion laser. All scanning parameters were kept constant throughout the different experiments. AIM 3.2 confocal microscope software (Carl Zeiss) was used for data acquisition and analysis.
###end p 40
###begin title 41
RT-PCR
###end title 41
###begin p 42
###xml 66 70 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Gackiere2">[29]</xref>
###xml 88 90 84 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 132 159 128 155 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGACCAATCCTCCTGTACCAC-3&#8242;</named-content>
###xml 174 202 170 198 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTCTGCATCTTTCATGTCCTAG-3&#8242;</named-content>
###xml 259 285 255 281 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGTGCTCCTGTTCTCCCTTC-3&#8242;</named-content>
###xml 300 327 296 323 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTTGTCGATGGCTTCCTTCAC-3&#8242;</named-content>
###xml 414 440 410 436 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTCACCACCATGGAGAAGGC-3&#8242;</named-content>
###xml 455 481 451 477 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGCATGGACTGTGGTCATGA-3&#8242;</named-content>
###xml 547 573 543 569 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGAGTCAGAGCTGGCACAGA-3&#8242;</named-content>
###xml 588 615 584 611 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGGTGTCATTGGTCTCAGACA-3&#8242;</named-content>
###xml 690 716 686 712 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGCGAGATGGAGCAGCAGAA-3&#8242;</named-content>
###xml 731 758 727 754 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGCCATCGTGCACATCCATGA-3&#8242;</named-content>
###xml 775 777 767 769 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
Reverse transcription-PCR was carried out as previously described [29]. The 178 pb alpha1A-AR isoform 1 amplicon was amplified with 5'-AGACCAATCCTCCTGTACCAC-3' (forward) and 5'-CTCTGCATCTTTCATGTCCTAG-3' (reverse). The 220 pb cav-1 amplicon was amplified with 5'-AGTGCTCCTGTTCTCCCTTC-3' (forward) and 5'-CTTGTCGATGGCTTCCTTCAC-3' (reverse) (Eurogentec). The 236 pb GAPDH amplicon internal control was amplified with 5'-TTCACCACCATGGAGAAGGC-3' (forward) and 5'-GGCATGGACTGTGGTCATGA-3' (reverse). The 241 pb cytokeratin 18 amplicon was amplified with 5'-TGAGTCAGAGCTGGCACAGA-3' (forward) and 5'-TGGTGTCATTGGTCTCAGACA-3' (reverse). Finally, the 210 pb cytokeratin 14 amplicon was amplified with 5'-TGCGAGATGGAGCAGCAGAA-3' (forward) and 5'-TGCCATCGTGCACATCCATGA-3' (reverse). alpha1A-AR, cav-1, cytokeratin 14 and 18 mRNA expressions were validated by gel density analysis by using GAPDH mRNA as internal control.
###end p 42
###begin title 43
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Tissue specimens
###end title 43
###begin p 44
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
###xml 128 135 <span type="species:ncbi:9606">patient</span>
Human BPH biopsies were obtained from consenting patients following the local ethical considerations. All experiments involving patient tissues were carried out under approval number 'CP 01/33', issued by the 'Comite Consultatif de Protection des Personnes dans la Recherche Biomedicale de Lille'.
###end p 44
###begin title 45
Statistical analysis
###end title 45
###begin p 46
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Results</xref>
###xml 92 93 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 199 205 197 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 270 271 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 282 283 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 299 300 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Results were expressed as the mean+/-SEM. Statistical analysis was performed using unpaired t tests (for comparing two groups) or analysis of variance tests followed by Dunnett (for multiple control versus test comparisons). Differences were considered significant when p<0.05 (*), p <0.01 (**) and p <0.001 (***).
###end p 46
###begin title 47
Results
###end title 47
###begin title 48
###xml 5 7 1 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
alpha1A-AR is associated with cav-1 at the DU145 cell surface
###end title 48
###begin p 49
###xml 61 63 57 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 78 82 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Fujita1">[15]</xref>
###xml 99 101 91 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 149 153 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Chini1">[14]</xref>
###xml 155 159 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Morris2">[30]</xref>
###xml 202 204 190 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 369 373 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Lamaze1">[26]</xref>
###xml 380 382 364 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 540 548 524 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g001">Figure 1</xref>
Previous studies have described a direct interaction of alpha1A-AR with cav-1 [15]. Moreover, alpha1A-AR signalling is known to localize in caveolae [14], [30]. To explore the membrane topology of alpha1A-AR, we used the "rip-off" technique developed in adherent cells allowing the isolation and observation by electron microscopy of large areas of the plasma membrane [26]. alpha1A-AR immunogold staining (6 nm dots, black arrowhead) colocalizes with cav-1 (18 nm dots, white arrowhead) in plasma membrane microdomains of about 50-100 nm (Figure 1).
###end p 49
###begin title 50
###xml 5 7 1 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
alpha1A-AR and cav-1 colocalization in DU145 cell surface.
###end title 50
###begin p 51
###xml 56 63 56 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 117 119 113 115 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 227 229 219 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
Plasma membranes were "ripped-off" as described in the "Methods" section and incubated with anti-cav-1 and anti-alpha1A-AR antibodies. Secondary antibodies coupled with 6 nm and 18 nm gold particles were used against anti-alpha1A-AR (black arrowhead) and anti-cav-1 (white arrowhead) respectively. Grids were then processed for electron microscopy observation. Colocalization of both proteins is indicated by circles. Bar, 200 nm.
###end p 51
###begin title 52
Plasma membrane protein redistribution and lipid composition alterations in DRM fractions induced by phenylephrine
###end title 52
###begin p 53
###xml 281 283 277 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 529 538 523 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g002">Figure 2A</xref>
###xml 965 974 959 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g002">Figure 2A</xref>
Analysis of plasma membrane microdomains, caveolae or lipid raft composition typically begins with detergent solubilization of whole cells followed by density gradient centrifugation and recovery of DRM from light fractions of the gradient. We investigated the association of alpha1A-AR with purified DRM from DU145 whole cell membrane extracts on an OptiPrep(R) density gradient. For the characterisation of DRM fractions, the presence of a specific plasma membrane marker pan cadherin was first assessed as a positive control (Figure 2A, a). Its presence in all 10 purified fractions demonstrates that the isolated DRM fractions correspond to plasma membrane regions. In addition, the nuclear protein PCNA (proliferation cell nuclear antigen) and the mitochondrial protein bax were used as negative controls as they are known not to associate with plasma membrane. Their absence in DRM fractions validates the absence of contamination by intracellular membranes (Figure 2A, a).
###end p 53
###begin title 54
###xml 72 74 68 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
Protein and lipid redistributions after agonist stimulation of the alpha1A-AR by phenylephrine.
###end title 54
###begin p 55
###xml 90 97 90 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 777 779 769 771 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 800 803 788 791 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q11</sub>
###xml 920 927 908 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 1212 1213 1200 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1223 1224 1211 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1235 1236 1223 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1252 1253 1240 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
(A) DRM fractions of increasing density (from fraction 1 to 10) obtained as indicated in "Methods" section and analyzed by Dot blot. (a) Pan cadherin was used as a positive control confirming that the fractions obtained correspond to plasma membrane. PCNA (proliferation cell nuclear antigen) and Bax were used as negative controls, their absence confirming the non-contamination of DRM fractions by intracellular proteins known not to be associated with rafts. (b) Dot blot of the DRM fraction collection in control condition (CTL) and 10 min treatment with 10 microM phenylephrine (PHE). Purinergic receptor P2Y2 was used as a negative control for the specificity of the effect of phenylephrine on protein redistribution in fractions. Black rectangle marks the shift of alpha1A-AR, cav-1 and Galphaq11 protein to lighter density fractions. (B) Lipid composition of the 10 fractions was quantified as described in the "Methods" section in control (black column) and PHE treated cells (grey columns) for (a) lysophosphatidylcholine (LPC), (b) phosphatidylcholine (PC), (c) sphingomyelin (SM), (d) cholesterol. Error bars represent SEM calculated from three independent experiments. Statistical analysis used the t test; *, p<0.05, **, p <0.01 and ***, p <0.001.
###end p 55
###begin p 56
###xml 87 89 83 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 145 147 137 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 330 332 318 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 520 522 500 502 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 600 609 580 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g002">Figure 2A</xref>
###xml 668 671 644 647 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q11</sub>
###xml 681 683 653 655 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 891 894 859 862 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q11</sub>
###xml 1089 1091 1053 1055 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1234 1243 1198 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g002">Figure 2A</xref>
In order to determine whether previously defined microdomains are involved in the alpha1A-AR signalling pathway in DU145 cells, we examined alpha1A-AR stimulation by its specific agonist phenylephrine (PHE). Dot blot analysis of DRM fractions revealed distribution of cav-1 in low density gradient (5%-20%) fractions 1-6 and alpha1A-AR in fractions 1 and 3-6 in control (CTL) conditions. After 10 minutes treatment by 10 microM PHE cav-1 distribution was observed in low density gradient (5%-10%) fractions 1-5 and alpha1A-AR was now detected in all fractions 1-6 (including low density fraction 2) (Figure 2A, b, upper panel CTL; lower panel PHE). Importantly, Galphaq11 (an alpha1A-AR effector) contents showed a shift from fractions 4-5 to fractions 1 to 5 after PHE treatment and remain present in higher density fractions, suggesting that receptor activation does not involve all Galphaq11 proteins present at the membrane level. We also assessed the purinergic receptor P2Y2 used as a negative control for the specificity of modification in protein distribution induced by PHE. alpha1A-AR and P2Y2 are both GPCR sharing similar signalling pathways. P2Y2 is located in the same fractions whether DU145 cells were treated or not (Figure 2A, b, CTL and PHE), therefore demonstrating the specificity of the previously observed PHE-induced modified protein distribution.
###end p 56
###begin p 57
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Brown1">[31]</xref>
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Simons1">[32]</xref>
###xml 542 551 542 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g002">Figure 2B</xref>
###xml 867 871 867 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-deAlmeida1">[33]</xref>
###xml 873 877 873 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Yuan1">[34]</xref>
###xml 1042 1044 1038 1040 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1066 1068 1058 1060 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
Moreover, we were interested in the lipid composition of purified DRM fractions. Lipids known to be enriched in biological lipid rafts, such as lysophosphatidylcholine (LPC), sphingomyelin (SM), phosphatidylcholine (PC) and cholesterol [31], [32], were analyzed. Once again, we investigated possible alterations of the lipid composition of DRM fractions after PHE stimulation. Our observations show a significant increase in the quantities of these lipids mainly in low density gradient (5%-10%) fractions 1-5 as a result of PHE stimulation (Figure 2B, a, b, c, d). These results are in agreement with the well established fact that the high lipid content causes floating of lipid microdomains in low density fractions during centrifugation. Previously published data on lipid model systems show that the size of lipid rafts depends on the lipid membrane composition [33], [34]. The observed alterations in lipid compositions due to membrane reorganization may account for lighter density microdomains resulting in the redistribution of alpha1A-AR, cav-1 and Galphaq11 observed within DRM fractions.
###end p 57
###begin title 58
Protein and lipid reorganization induced by phenylephrine is associated with cav-1-rich membrane clustering
###end title 58
###begin p 59
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Kusumi1">[35]</xref>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Parton1">[36]</xref>
###xml 272 274 268 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 370 379 366 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g003">Figure 3A</xref>
###xml 492 501 484 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g003">Figure 3A</xref>
###xml 540 549 532 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g003">Figure 3A</xref>
###xml 719 728 711 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g003">Figure 3A</xref>
###xml 845 854 837 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g003">Figure 3A</xref>
It is thought that upon extracellular stimulus, the plasma membrane is prepared for the formation of more stabilized domains and molecular clusters with enhanced size and lifetime such as caveolae [35], [36]. In order to understand the involvement of caveolae in the alpha1A-AR signalling, we explored the effect of PHE stimulation on the DU145 cell surface morphology (Figure 3A). Cells treated for 10 min with 10 microM PHE present numerous surface invaginations corresponding to caveolae (Figure 3A, b) as compared to non-treated cells (Figure 3A, a). Caveolae are evident as circular profiles with uniform shape and 50-80 nm diameter. In this representative electron micrograph caveolae are present as single pits (Figure 3A, b, black arrowheads) and sometimes in more complex arrangements interconnected with cytoplasmic caveolar profiles (Figure 3A, b, white arrowheads).
###end p 59
###begin title 60
###xml 69 71 65 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
Cell surface modification and caveolin-1 mobilization following alpha1A-AR stimulation.
###end title 60
###begin p 61
###xml 545 547 529 531 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 809 811 789 791 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
(A) Representative electron micrograph of DU145 cells in (a) non-treated condition (b) after 10 min treatment by 10 microM PHE. Caveolae and caveolin containing vesicles of 50-80 nm diameter are dense in electrons are indicated by black arrowheads. White arrowheads indicate complex shaped caveolae. Bar, 500 nm. (B) Representative electron micrograph of plasma membrane "ripped-off" from (a) non-treated cells, (b) treated for 10 min with 10 microM PHE alone and (c) PHE in the presence of 1 microM PRA. 6 nm gold particles represent anti-alpha1A-AR labelling (black arrowheads) and 12 nm particles represent anti-cav-1 (white arrowheads). Bar, 200 nm. (d) The area of randomly selected negatives of electron micrographs (ten/condition) was measured at a magnification of 20000. The number of cav-1 and alpha1A-adrenoceptor-containing clusters (minimum 3 gold particles for each protein) was counted (mean +/- SEM).
###end p 61
###begin p 62
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Parton1">[36]</xref>
###xml 242 244 238 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 285 287 277 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 304 313 296 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g003">Figure 3B</xref>
###xml 467 476 459 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g003">Figure 3B</xref>
###xml 639 648 631 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g003">Figure 3B</xref>
###xml 688 697 680 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g003">Figure 3B</xref>
###xml 811 813 799 801 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 834 835 818 819 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 891 900 875 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g003">Figure 3B</xref>
###xml 1003 1005 983 985 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1105 1107 1081 1083 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1159 1161 1131 1133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1278 1280 1246 1248 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
Caveolae are formed by the polymerisation of caveolins leading to the clustering and invagination of existing cholesterol-sphingolipid rich domains in the cell plasma membrane [36]. We investigated the membrane distribution of cav-1 and alpha1A-AR in control conditions and after alpha1A-AR stimulation (Figure 3B). The same surface areas of preparations (ten/condition) were compared in control and treated conditions and the mean number of clusters was calculated (Figure 3B, d). Here, representative electron micrographs for each condition are presented. We observed a greater number of cav-1-rich domains in PHE treated cell surfaces (Figure 3B, b) as compared to control conditions (Figure 3B, a). Further, in order to test the specificity of PHE stimulation on cell surface distribution of cav-1 and alpha1A-AR, we used an alpha1-AR antagonist, prazosin (PRA) simultaneously with PHE (Figure 3B, c). Cav-1 was present in isolated units and not in clusters at the cell surface associated with alpha1A-AR. It should be noted that PRA alone did not affect membrane localization of either cav-1 or alpha1A-AR (data not shown). Our results propose that alpha1A-AR may associate with cav-1 in resting cells and upon receptor stimulation clustering of cav-1-rich units form alpha1A-AR-containing structural surface caveolae.
###end p 62
###begin title 63
Phenylephrine sensitizes DU145 cells' resistance to Thapsigargin-mediated apoptosis through the caspase-3 pathway in a cav-1 dependent manner
###end title 63
###begin p 64
###xml 190 199 190 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4A</xref>
###xml 382 384 378 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
We first quantified cav-1 in DU145 non-transfected cells (DU145 WT) and in stably transfected DU145 cells with either an empty plasmid (DUshCTL) or a plasmid expressing shRNA against cav-1 (Figure 4A, a). These cav-1 knockdown cells express 60% less cav-1 than non-transfected or shCTL cells. The use of these cells allowed us to investigate the involvement of caveolae in the alpha1A-AR signalling as it is further explained.
###end p 64
###begin title 65
Apoptosis resistance of DU145 cells depends on caveolin-1 expression and is mediated by the caspase-3 pathway.
###end title 65
###begin p 66
###xml 887 888 879 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 898 899 890 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1541 1542 1531 1532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1552 1553 1542 1543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1564 1565 1554 1555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1581 1582 1571 1572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
(A)(a) Western blot showing the expression of caveolin-1 (cav-1) in DU145 cells stably transfected with Psuper plasmid expressing shRNA against cav-1 (DUshcav-1) and with empty Psuper plasmid (DUshCTL). Images are grouped from different lanes of the same gel and numbers above gels indicate relative expression assessed on actin expression. (b) Cells were treated during 48 hrs with 10 microM Thapsigargin (TG) for induction of apoptosis, preceded by a 3-day renewable treatment with 10 microM phenylephrine alone (PHE+TG) or simultaneously with prazosin (PRA+PHE+TG), then analyzed by flow cytometry of propidium iodide-stained nuclei. Experiments were carried out in DU145 non-transfected cells (DU145 WT, white columns), DUshCTL cells (black columns) and DUshcav-1 cells (grey columns). Error bars represent SEM calculated from four independent experiments. Statistical analysis used t test; *, p<0.05, **, P<0.01. (B)(a) Expression levels of pro-caspase 3 and PARP (full-length and cleaved fragment) in DU145 WT, DUshCTL and DUshcav-1, after treatments indicated above were determined by western blot analysis and analyzed by scanning densitometry using actin immunoblotting (for procaspase-3) and calnexin (for cleaved PARP) as internal controls. (b, c, d) Average densitometries are represented by histograms for non-transfected (white columns), control shRNA (black columns) and caveolin-1 shRNA expressing cells (grey columns). Plots are the average cumulative data (mean +/- SEM) of three experiments. Statistical analysis used the t test; *, p<0.05, **, p <0.01 and ***, p<0.001.
###end p 66
###begin p 67
###xml 35 37 31 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 483 487 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Wertz1">[37]</xref>
###xml 599 603 591 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Kajstura1">[38]</xref>
###xml 811 820 803 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007068.s001">Figure S1</xref>
###xml 949 958 941 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4A</xref>
In order to study the role of alpha1A-AR signalling in the survival of DU145 cells, we induced cell apoptosis by a 48 h treatment with 10 microM thapsigargin (TG), a known inhibitor of sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA). As a consequence of inhibiting SERCA, TG induces a substantial depletion of calcium stores, creating perturbations in cellular calcium known as reticular stress coupled with the ability to engage mitochondrial-dependent apoptotic pathways [37]. In the present study, apoptosis was measured as an increased number of cells in SubG1 phase of the cell cycle [38]. It should be noted that the percentage of apoptotic cells in non-treated conditions was close to 0% and a 48 h TG treatment induced an increase of cells in SubG1 phase to about 20% (Supporting Information, Figure S1). In order to assess the effect of PHE on the TG-induced apoptosis, here we considered TG-treated cells as 100% in SubG1 phase (Figure 4A, b) and different treatments were therefore compared to TG-treated conditions.
###end p 67
###begin p 68
###xml 217 226 213 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4A</xref>
###xml 265 266 257 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 483 492 471 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4A</xref>
###xml 625 634 613 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007068.s001">Figure S1</xref>
###xml 919 928 907 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4A</xref>
###xml 1030 1039 1018 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007068.s002">Figure S2</xref>
A three-day pre-treatment by 10 microM PHE prior to TG treatment induced a significant 25% decrease in the number of DU145 WT cells (white columns) in SubG1 phase as well as a 20% decrease in DUshCTL (black columns) (Figure 4A, b). In order to demonstrate the alpha1-AR specificity of the apoptosis resistance induced by PHE, PRA was simultaneously used with PHE. Indeed, the resistance to TG-induced apoptosis was abolished when 1 microM PRA was added to the pretreatment solution (Figure 4A, b, black and white columns). It should be noted that PHE or PRA alone have no effect on cell cycle phases (Supporting Information, Figure S1, D). We then sought to investigate the involvement of caveolae in this phenomenon. We therefore disrupted caveolae structure by underexpressing cav-1. Analysis of SubG1 phase revealed that in cav-1 knockdown cells PHE pre-treatment did not promote resistance to TG-induced apoptosis (Figure 4A, b, grey columns). All these results were confirmed by the Hoechst staining (Supporting Information, Figure S2). The present findings strongly suggest the involvement of caveolae in the resistance to TG-induced apoptosis mediated by PHE in DU145 cells.
###end p 68
###begin p 69
###xml 208 217 208 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4B</xref>
###xml 342 351 342 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4B</xref>
###xml 475 484 475 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4B</xref>
###xml 626 635 626 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4B</xref>
###xml 775 784 775 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4B</xref>
###xml 998 1007 994 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4B</xref>
###xml 1202 1211 1194 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4B</xref>
###xml 1385 1394 1377 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4B</xref>
We then explored the expression of target proteins known to regulate mechanisms of apoptosis induction or resistance such as the caspases and the poly (ADP-ribose) polymerase (PARP) by western blot analysis (Figure 4B, a). Scanning densitometry allowed us to represent relative average densities of three different experiments by histograms (Figure 4B, b, c and d). We first assessed the expression of the 32 kD protein procaspase 3 in DU145 WT, DUshCTL and DUshcav-1 cells (Figure 4B, a). Our results in DU145 WT and DUshCTL cells showed a decrease of procaspase 3 after TG treatment due to its cleavage to active caspase 3 (Figure 4B, a), reflecting the induction of apoptosis and indicated respectively by a 60-80% decrease in intensity represented by the average ratios (Figure 4B, b, white and black columns). The TG-induced decrease of procaspase 3 was reversed by 60% and 134% respectively when DU145 WT and DUshCTL cells were pre-treated with 10 microM PHE, indicating decreased apoptosis (Figure 4B, a and c, white and black columns). Further, when 1 microM PRA was used simultaneously with PHE, procaspase 3 levels were similar to TG alone pointing out the antagonistic action of PRA to PHE (Figure 4B, a and c, white and black columns). On the contrary, in DUshcav-1 cells, PHE alone or in the presence of PRA did not reverse the 66% decrease of procaspase 3 induced by TG (Figure 4B, a and c, grey columns).
###end p 69
###begin p 70
###xml 101 108 101 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Tewari1">[39]</xref>
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Lazebnik1">[40]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Oliver1">[41]</xref>
###xml 361 370 361 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4B</xref>
###xml 502 509 502 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 695 704 691 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4B</xref>
###xml 850 859 842 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4B</xref>
###xml 1006 1015 998 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4B</xref>
###xml 1124 1125 1112 1113 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
PARP, a 116 kD nuclear poly (ADP-ribose) polymerase is one of the main cleavage targets of caspase-3 in vivo[39]. Cleavage separates the PARP amino-terminal DNA binding domain (24 kD) from the carboxy-terminal catalytic domain (89 kD) [40] and serves as a marker of cells undergoing apoptosis [41]. In all our cell lines, TG treatment induced cleavage of PARP (Figure 4B, a), revealed by an antibody which recognizes both the full-length 116 kD fragment as well as the 89 kD cleaved fragment (see the "Methods" section). A three-day treatment by 10 microM PHE preceding TG reduced the amount of cleaved PARP by 30% and 35% suggesting decreased apoptosis in DU145 and DushCTL cells respectively (Figure 4B, a and d, white and black columns). 1 microM PRA pretreatment opposed the PHE-induced decrease in PARP cleavage only in DU145 and DUshCTL cells (Figure 4B, a and d, white and black columns). In Dushcav-1 cells, PHE treatment with or without PRA had no effect in PARP cleavage as compared to TG alone (Figure 4B, a and d, grey columns) once again strongly suggesting the involvement of caveolae in this function of alpha1-AR.
###end p 70
###begin title 71
TG-induced apoptosis resistance in DU145 cells is also mediated by a Bcl-2 family protein in a cav-1 dependent manner
###end title 71
###begin p 72
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Youle1">[42]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Lalier1">[43]</xref>
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Tsujimoto1">[44]</xref>
###xml 665 672 665 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 776 785 776 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g005">Figure 5A</xref>
###xml 806 815 806 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g005">Figure 5B</xref>
###xml 841 850 841 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g005">Figure 5C</xref>
###xml 940 958 940 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g005">Figure 5A, B and C</xref>
###xml 1078 1093 1074 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g005">Figure 5A and B</xref>
###xml 1133 1148 1129 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g005">Figure 5A and B</xref>
###xml 1302 1317 1294 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g005">Figure 5A and B</xref>
###xml 1467 1476 1459 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g005">Figure 5C</xref>
###xml 1574 1575 1562 1563 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Bax is a 23 kD pro-apoptotic protein, member of the Bcl-2 family. The critical events in the activation process of Bax are: its translocation to mitochondria and its N-terminal conformational change closely coupled to mitochondrial membrane insertion and oligomerisation [42], [43]. The insertion of Bax into the mitochondrial outer membrane is closely associated with the release into the cytosol of several proteins such as cytochrome c and procaspase-3 which are essential to the execution of the apoptotic program [44]. We investigated Bax activation by immunofluorescence using an antibody which specifically recognizes the activated conformation of Bax (see "Methods" section). The figures shown here are representative of all slides observed. TG treatment of DU145 WT (Figure 5A, b), DUshCTL cells (Figure 5B, b) and Dushcav-1 cells (Figure 5C, b) induced an increase in activated-Bax staining as compared to non-treated conditions (Figure 5A, B and C, a). In DU145 and DushCTL cells, a three-day treatment by 10 microM PHE preceding TG reduced activated-Bax expression (Figure 5A and B, c) as compared to TG treatment alone (Figure 5A and B, b) suggesting decreased apoptosis in these conditions. Once more, 1 microM PRA pretreatment opposed the PHE-induced decrease in activated-Bax staining (Figure 5A and B, d). No significant consequence of PHE pretreatment (with or without PRA) in the resistance to TG-induced apoptosis was observed in DUshcav-1 cells (Figure 5C, b, c and d) once again strongly suggesting the involvement of caveolae in this function of alpha1-AR. DAPI-stained nuclei are indicative of the number of cells present in the observation field. The absence of apoptotic figures (chromatin condensation and nuclear fragmentation) in cells expressing activated Bax is expectable as Bax activation is an early-stage apoptotic process as opposed to nuclear fragmentation.
###end p 72
###begin title 73
###xml 65 68 65 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
PHE enhances TG-induced apoptosis resistance in DU145 cells also via bax activation.
###end title 73
###begin p 74
Representative immunofluorescence of (A) DU145, (B) DushCTL and (C) Dushcav-1 cells in (a) non-treated conditions, (b) 10 microM TG for 48 h, (c) 10 microM PHE 3-day pretreatment (d) with the presence of 1 microM PRA, followed by 10 microM TG for 48 h showing the presence of activated Bax recognised by the anti-bax (6A7) antibody. The presence of cells in the observation field is indicated by DAPI-stained nuclei. Bar, 50 microm.
###end p 74
###begin title 75
###xml 57 59 53 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 111 116 <span type="species:ncbi:9606">human</span>
Expression and localization variations of cav-1 and alpha1A-AR are associated with pathological alterations of human prostate tissue
###end title 75
###begin p 76
###xml 9 11 5 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 92 96 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Lepor1">[45]</xref>
###xml 98 102 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Nasu2">[46]</xref>
###xml 318 322 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Li1">[47]</xref>
###xml 324 328 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Tahir1">[48]</xref>
###xml 367 369 359 361 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 494 496 482 484 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 877 879 861 863 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 929 931 909 911 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 962 971 942 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g006">Figure 6A</xref>
###xml 1039 1041 1015 1017 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1194 1198 1170 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Karam1">[49]</xref>
###xml 1230 1232 1202 1204 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1302 1304 1270 1272 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1388 1397 1356 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g006">Figure 6A</xref>
###xml 1473 1475 1437 1439 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1605 1614 1569 1578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g006">Figure 6A</xref>
###xml 1730 1732 1690 1692 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1835 1844 1795 1804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g006">Figure 6A</xref>
###xml 1940 1942 1896 1898 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 581 589 <span type="species:ncbi:9606">patients</span>
###xml 724 732 <span type="species:ncbi:9606">patients</span>
The alpha1A-AR is abundant in the fibromuscular tissue in normal and hyperplastic prostates [45], [46] however, its role in prostate epithelial cells is still not well defined. Moreover, cav-1 has been described to play an important role in the survival/growth of PCa cells contributing to their metastatic activities [47], [48]. To determine the association of alpha1A-AR and cav-1 expression with established features of PCa as well as BPH in comparison to normal prostate, we performed alpha1A-AR and cav-1 immunostaining on tissue microarrays containing specimen cores from 40 patients. Cytokeratin 18 immunostaining was used as a label of apical epithelial cells present in acini. Normal tissue regions from 9 of these patients were present on these slides. The figures shown here are representative of all samples observed. We first confirmed the specificity of the alpha1A-AR antibody by the use of two siRNA against alpha1A-AR (siADR1A-1 and siADR1A-2) (Figure 6A, a). The use of these siRNA induced a 40% and 60% decrease of alpha1A-AR as compared to DU145 cells transfected with the control siRNA. Previous studies revealed that cav-1 overexpression is associated with aggressive PCa [49] but little is known about alpha1A-AR expression in PCa progression. Here, we found that cav-1 and alpha1A-AR were strongly expressed in luminal, invasive epithelial cells in stage III PCa (Figure 6A, b, cancerous acinus). Furthermore, in hyperplastic tissues cav-1 and alpha1A-AR immunostaining was present in the simple lining of cytokeratin 18-positive-acinar epithelium and in the fibromuscular stroma (Figure 6A, b, hyperplastic acinus). The majority of the normal regions of the samples expressed low levels of cav-1 and alpha1A-AR in apical epithelial cells and the presence of the two proteins was mostly observed in the stroma (Figure 6A, b, normal acinus). Overall, these results demonstrated elevated expressions of cav-1 and alpha1A-AR in advanced PCa epithelial cells, more numerous and invasive in these conditions than in BPH.
###end p 76
###begin title 77
###xml 5 7 1 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 84 89 <span type="species:ncbi:9606">human</span>
alpha1A-AR and cav-1 differential expressions in normal, cancerous and hyperplastic human prostate.
###end title 77
###begin p 78
###xml 51 53 47 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 112 114 104 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 409 411 397 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 743 745 723 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 963 965 931 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1262 1263 1230 1231 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1292 1294 1260 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MW</italic>
###xml 1423 1425 1387 1389 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1713 1714 1675 1676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1724 1725 1686 1687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1736 1737 1698 1699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
(A)(a) Western blot showing the expression of alpha1A-AR in DU145 cells transfected with two siRNA against alpha1A-AR (siADR1A-1 and siADR1A-2) and control siRNA (siCTL). Numbers above gels indicate relative densitometry assessed on actin expression. (b) Representative immunofluorescence of normal prostate acinus showing the presence of the apical epithelial marker cytokeratin 18 (cytk 18, green) and alpha1A-AR or cav-1 fluorescence (red); Bar, 50 microm. Star indicates the acinus lumen and white arrowhead fibromuscular stroma. The middle left panel shows representative stage III cancerous acinus. Typically, cancerous apical epithelial cells detected with cytokeratin 18 (green) have completely invaded the lumen and express both alpha1A-AR and cav-1 (red); Bar, 50 microm. The middle right panel shows a section of a representative hyperplastic acinus where the lumen (star) is enlarged; Bar, 20 microm. (B)(a) Agarose gel showing the expression of alpha1A-AR (178 pb), cav-1 (220 pb), cytokeratin 18 (241 pb) and cytokeratin 14 (210 pb) amplicons in six different prostatic androgen-independent carcinoma tissues and six different benign hyperplasia tissues. A no-template control was also run with the PCR samples where cDNA was replaced with water (H2O). A 1-kilobase DNA ladder (MW (bp)) was used as a DNA size marker. GAPDH (236 pb) was used as an internal control. (b) Ratios of mean mRNA quantities of alpha1A-AR, cav-1, cytokeratin 18 (cytk 18) and 14 (cytk 14) as compared to GAPDH in androgen-independent (AI) cancer (black columns) and hyperplastic samples (grey hatched columns). Plots are the average cumulative data (mean +/- SEM) of six samples by condition. Statistical analysis used the t test; *, p<0.05, **, p<0.01.
###end p 78
###begin p 79
###xml 65 67 61 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 289 298 285 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g006">Figure 6B</xref>
###xml 336 338 328 330 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 423 432 415 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g006">Figure 6B</xref>
###xml 475 477 463 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 554 563 542 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g006">Figure 6B</xref>
###xml 1078 1080 1062 1064 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1395 1397 1375 1377 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1540 1542 1516 1518 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1557 1560 1533 1536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 123 128 <span type="species:ncbi:9606">human</span>
###xml 189 197 <span type="species:ncbi:9606">patients</span>
###xml 1290 1298 <span type="species:ncbi:9606">patients</span>
Finally, we were interested in assessing the mRNA levels of alpha1A-AR and cav-1 in a series of cancerous and hyperplastic human prostate samples. We analyzed six PCa samples obtained from patients in hormone-refractory phase and characterized as androgen-independent and six BPH samples (Figure 6B, a). Relative quantification of alpha1A-AR and cav-1 mRNA levels as compared to GAPDH internal control was quite promising (Figure 6B, b). We found average mRNA levels of alpha1A-AR and cav-1 more elevated in androgen-independent PCa samples than in BPH (Figure 6B, b, black and hatched grey columns). Noticeably, cytokeratin 18 mRNA was more abundant in androgen-independent cancer samples than BPH, in agreement with our previous observations in immunofluorescence. Finally, we noticed that basal epithelial cells' marker cytokeratin 14 mRNA levels did not present any variations between androgen-independent prostate cancer and BPH (except for sample C2 for which no information is available to allow an explanation for its non-detection). Our data strongly suggest that alpha1A-AR may be associated with androgen-independent PCa epithelial cells and advanced stage PCa just like cav-1. Regardless of internal variability of hyperplastic and cancerous samples (related to factors such as patients' age, progression of disease, treatment) we underlined significant elevated mRNA levels of alpha1A-AR and cav-1 in androgen-independent cancer compared to BPH. We propose that their simultaneous expression could account in part for the alpha1A-AR signalling via caveolae in androgen-independent PCa epithelial cells.
###end p 79
###begin title 80
PHE protection from TG-induced apoptosis in DU145 cells involves activation of the ERK1/2 signalling pathway
###end title 80
###begin p 81
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Gioeli1">[50]</xref>
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Price1">[51]</xref>
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Shaul1">[52]</xref>
###xml 315 317 311 313 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1B</sub>
###xml 364 367 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 424 428 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Bruchas1">[53]</xref>
###xml 739 748 731 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g007">Figure 7A</xref>
###xml 893 902 881 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g007">Figure 7A</xref>
###xml 1081 1090 1069 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g007">Figure 7B</xref>
###xml 1383 1392 1359 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g007">Figure 7B</xref>
###xml 1441 1450 1417 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4B</xref>
It is now well established that ERKs are overexpressed in advanced stage prostate cancer and play a significant role in prostate tumorigenesis [50], [51]. This family of serine/threonine kinases is involved in transmitting signals regulating cell survival and growth [52]. Recently, is has been shown that the alpha1B-AR activates ERK in submandibular gland cells via a mechanism dependent of membrane microdomain integrity [53]. In the present study, we were interested in assessing PHE-induced activation of ERK1/2 and the potential involvement of this signalling pathway in the TG-induced apoptosis resistance described in DU145 cells. A 30 min treatment by 10 microM PHE induced activation by phosphorylation of ERK1/2 (p44/p42 MAPK) (Figure 7A, a and b). We used the specific inhibitor of ERK1/2 phosphorylation, 10 microM PD98059, which drastically decreased amount of activated ERK1/2 (Figure 7A, a and b). In order to demonstrate the involvement of ERK1/2 in the TG-induced apoptosis resistance in DU145 cells, we assessed PARP cleavage, indicating induction of apoptosis (Figure 7B). Interestingly, after simultaneous pretreatment of DU145 cells by 10 microM PHE and 10 microM PD98059 followed by 10 microM TG, we detected a 2-fold increase of cleaved PARP (89 kD) as compared to PHE alone followed by TG, strongly suggesting increased apoptosis in the presence of PD98059 (Figure 7B, a, lanes 4 and 5, b). As previously described (Figure 4B, a and d) TG alone induced a higher level of PARP cleavage as compared to PHE-pretreatment conditions (lanes 6 and 4). It should also be noted that PARP cleavage was similar in TG treatment conditions alone or in the presence of PD98059 and that PHE and/or PD98059 alone did not induce PARP cleavage (lanes 2, 3 and 8).
###end p 81
###begin title 82
TG-induced apoptosis resistance in DU145 cells is mediated by ERK1/2.
###end title 82
###begin p 83
###xml 1079 1080 1041 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1092 1093 1054 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
(A)(a) Western blot showing expression of phosphorylated p44/p42 MAPK (ERK1/2) in non-treated cells (CTL), 30 min treatment by 10 microM PHE (PHE 30 min) and simultaneous treatment by 10 microM PHE and 10 microM PD98059 (PHE+PD98059). (b) Expression of phospho-p44 and phospho-p42 MAPK is assessed on total p44/p42 MAPK in DU145 cells. (B)(a) Western blot showing expression of PARP full length fragment (116 kD) and cleaved PARP (89 kD) in the following treatment conditions: non-treated (CTL), 30 min or 72 h treatment by 10 microM PHE (PHE 30 min, PHE 72 h), pre-treatment by PHE alone or in the presence of 10 microM PD98059 followed by 48 h treatment by 10 microM TG (PHE+TG and PHE+PD98059+TG), 48 h treatment by 10 microM TG alone (TG) or preceded by 10 microM PD98059 pre-treatment (PD98059+TG) and 10 microM PD98059 treatment alone. (b) Expression of cleaved PARP is assessed on calnexin used as internal control for PHE+TG and PHE+PD98059+TG treatment conditions. Plots are the average cumulative data (mean +/- SEM) of three experiments. Statistical analysis used the t test; ***, p<0.001.
###end p 83
###begin title 84
Discussion
###end title 84
###begin p 85
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Raj1">[54]</xref>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Daaka1">[55]</xref>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Taub1">[56]</xref>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Gohji1">[57]</xref>
Various locally produced and circulating factors maintain prostate cancer growth by acting through cellular receptors. Increasing evidence supports the involvement of GPCR in neoplastic transformation of the prostate [54], [55]. Moreover, cancerous prostate expresses increased levels of GPCR and their ligands (for example bradykinin, endothelin and their corresponding receptors) [56], [57] suggesting that GPCR signalling may always be "switched on" therefore contributing to the initiation and progression of the disease.
###end p 85
###begin p 86
###xml 66 68 62 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 100 104 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Kojima1">[58]</xref>
###xml 106 110 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Kyprianou2">[59]</xref>
###xml 166 168 158 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 266 270 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Fujita1">[15]</xref>
###xml 272 276 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Morris1">[16]</xref>
###xml 407 411 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Williams1">[18]</xref>
###xml 413 417 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Goetz1">[60]</xref>
###xml 586 590 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Mouraviev1">[61]</xref>
###xml 592 596 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Yang1">[20]</xref>
###xml 598 602 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Karam1">[49]</xref>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 352 357 <span type="species:ncbi:9606">human</span>
A growing number of recent data has shown the involvement of alpha1A-AR in human prostate pathology [58], [59]. Further lines of evidence have demonstrated that alpha1A-AR and its effector proteins are differentially distributed in surface caveolae of cardiac cells [15], [16]. Caveolae and cav-1 have been described to play prominent roles in various human disease phenotypes including cancer (for reviews [18], [60]). Interestingly, the expression of cav-1 has been identified to be closely associated with PCa malignant progression and highly expressed in androgen-independent cells [61], [20], [49].
###end p 86
###begin p 87
###xml 73 75 69 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 284 286 276 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 590 592 578 580 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 828 832 816 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Simons2">[62]</xref>
###xml 897 899 881 883 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
Despite the above findings, the precise surface localization of the alpha1A-AR in androgen-independent PCa epithelial cells and its functional role in the proliferation and survival of these cells remain unknown. The present study is the first to demonstrate the localization of alpha1A-AR in caveolae of the androgen-independent PCa epithelial cells DU145. Our results from the exploration of the lipid-protein contents of purified DRM from these cells were particularly revealing. Noticeably, we provide evidence of significant increase in DRM lipids upon agonist stimulation of the alpha1A-AR. We propose that this elevated content of raft-specific lipids consequently leads to alterations of DRM density as it is known that high lipid composition causes floating of membranes to lower density fractions after centrifugation [62]. Our results after dot blot analysis strongly suggest that alpha1A-AR and cav-1 content is accordingly distributed toward lower density fractions.
###end p 87
###begin p 88
###xml 273 275 269 271 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 481 485 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Parton1">[36]</xref>
###xml 825 829 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Wang1">[63]</xref>
###xml 1086 1090 1082 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-deAlmeida1">[33]</xref>
###xml 1092 1096 1088 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Yuan1">[34]</xref>
###xml 1193 1197 1189 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Collins1">[64]</xref>
Furthermore, lipid composition alterations may be explained by coalescence of cav-1-containing membranes. In agreement with this suggestion, we observed a remarkable surface membrane reorganisation and formation of a great number of cav-1-rich invaginations following alpha1A-AR stimulation. It is well established that caveolae are formed by the polymerisation of caveolins, leading to the clustering and invagination of a subset of sphingolipid/cholesterol-rich membrane domains [36]. The trafficking of intracellular caveolin-containing membranes and their fusion with the plasma membrane could supply domains with cav-1 and lipids for caveolae formation. Besides it has been described that lipid redistribution in the plasma membrane may modify the biophysical properties of microdomains and regulate signalling pathways [63]. The exact relationship between microdomain composition, density and size is not well established to date. What is known though from previously published data on lipid model systems is that the size of lipid rafts depends on the lipid membrane composition [33], [34] strongly implying that cells could tune their membrane composition to create or destroy domains [64].
###end p 88
###begin p 89
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Drab1">[65]</xref>
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Fra1">[66]</xref>
###xml 205 207 201 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 222 226 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Dreja1">[67]</xref>
###xml 228 232 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Neidhold1">[68]</xref>
###xml 272 274 264 266 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 395 397 383 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 525 527 509 511 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
A large body of work indicates that cav-1 expression is essential for caveolae formation and function [65], [66]. Moreover, it has been demonstrated in cardiac cells that caveolae integrity regulates alpha1A-AR signalling [67], [68]. It is essential to note that all alpha1A-AR may not necessarily be associated to caveolae. In order to study the importance of the caveolar localisation of alpha1A-AR, we examined its functional role in the presence and absence of cav-1. We demonstrated that agonist stimulation of the alpha1A-AR enhanced resistance to reticular stress-induced apoptosis in DU145 cells through the Bax and the caspase-3 pathway. Importantly, we found that cells underexpressing cav-1 showed no resistance to TG-induced apoptosis, thus implying the necessity of caveolae integrity in this process.
###end p 89
###begin p 90
###xml 39 41 35 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 127 130 123 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 245 249 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Nasu1">[21]</xref>
###xml 251 255 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Li1">[47]</xref>
###xml 257 261 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Thompson1">[22]</xref>
###xml 295 297 287 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 359 361 347 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 384 387 372 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
Our results strongly suggest that alpha1A-AR signalling in DU145 cells contributes to their resistance to TG-induced apoptosis via caveolae. Additionally, our data add to the growing evidence that cav-1 promotes survival and growth of PCa cells [21], [47], [22]. The elevated expression of alpha1A-AR and cav-1 in DU145 cells may contribute to favouring alpha1A-AR signalling pathway via caveolae amplifying the effects on the survival of these cells.
###end p 90
###begin p 91
###xml 41 43 37 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 170 172 162 164 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 280 282 268 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 548 552 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Schroder1">[69]</xref>
###xml 739 741 723 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 868 870 848 850 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1034 1036 1010 1012 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1102 1106 1078 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Lepor1">[45]</xref>
###xml 1108 1112 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Marshall1">[70]</xref>
###xml 1114 1118 1090 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Takeda1">[71]</xref>
###xml 1172 1174 1144 1146 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1294 1296 1262 1264 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
To date, no relevant data describes alpha1A-AR expression variations according to prostate pathological state. Our study was innovative in the investigation of both alpha1A-AR and cav-1 expression in normal, cancerous and BPH samples. We show that the elevated expression of alpha1A-AR in prostate epithelial cells is correlated with prostate pathological progression. During prostate cancer, the organ's architecture is greatly compromised, characterized among others, by proliferation of epithelial cells and invasion of prostate ducts and acini [69]. Our immunohistofluorescent study provides evidence of numerous cytokeratin-18-positive (apical epithelial) cells invading acini in advanced PCa samples highly expressing cav-1 and alpha1A-AR as compared to normal or hyperplastic prostate. Accordingly, we demonstrated increased mRNA levels of cytokeratin-18, alpha1A-AR and cav-1 in androgen-independent PCa samples as compared to BPH samples. In agreement with previously published data our results propose that the role of alpha1A-AR in BPH is related to its presence in the fibromuscular stroma [45], [70], [71]. Further, elevated expression of both cav-1 and alpha1A-AR in advanced stage PCa epithelial cells provide a strong rationale for the understanding of the significance of alpha1A-AR signalling in androgen-independent PCa.
###end p 91
###begin p 92
###xml 183 185 183 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Humez1">[72]</xref>
###xml 276 278 276 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 425 427 425 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 453 455 449 451 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 533 535 525 527 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 667 671 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Clerk1">[73]</xref>
###xml 673 677 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Taguchi1">[74]</xref>
###xml 742 744 730 732 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 787 791 775 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Huang1">[75]</xref>
###xml 923 925 907 909 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 1153 1157 1137 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Gioeli1">[50]</xref>
###xml 1159 1163 1143 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007068-Price1">[51]</xref>
###xml 1027 1032 <span type="species:ncbi:9606">human</span>
Previous work from our laboratory has demonstrated that TG-induced apoptosis as well as apoptosis resistance induced by EGF in DU145 cells are mechanisms dependent of intracellular Ca2+ signalling [72]. We have observed that PHE treatment has no affect on the intracellular Ca2+ concentration (data not shown). This observation strongly suggests that resistance to TG-induced apoptosis in DU145 by PHE does not involve the Ca2+ signalling pathway. alpha1A-AR signalling is complex and various lines of evidence demonstrate that alpha1A-AR stimulation can activate a variety of signalling pathways depending on cell type, receptor expression and agonist concentration [73], [74]. It has been previously described, in cardiomyocytes, that alpha1A-AR activate ERK-related survival pathways [75]. We have revealed, for the first time, the involvement of the ERK1/2 MAPK pathway in the apoptosis resistance function of the alpha1A-AR in DU145 androgen-independent prostate cancer cells. Interestingly, it has been demonstrated that human prostate biopsies have increased levels of activated ERKs in malignant tissues as compared to those in benign specimens [50], [51].
###end p 92
###begin p 93
###xml 157 159 153 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 224 226 216 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 284 286 272 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 507 509 491 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 513 516 497 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 369 374 <span type="species:ncbi:9606">human</span>
In conclusion, we demonstrate that caveolae of androgen-independent prostate cancer cells DU145 are involved in the apoptosis resistance induced by the alpha1A-AR. Our data show that caveolae integrity is necessary for alpha1A-AR function in these cells. This study reveals that alpha1A-AR and cav-1 expressions are positively correlated with the pathological state of human prostate and are highly expressed in advance PCa tissue samples. Our data strongly suggest that the protective function of the alpha1A-AR via caveolae described in DU145 cells, may contribute in synergy with other factors, to the apoptosis resistance mechanisms of PCa cells and enhancement of their survival.
###end p 93
###begin title 94
Supporting Information
###end title 94
###begin p 95
###xml 163 170 163 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
Representative cell cycle profiles of propidium iodide (PI)-stained (A) DU145, (B) DUshCTL and (C) DUshcav-1 cells obtained by flux cytometry as described in the "Methods" section. (a) Non-treated cells, (b) cells treated by 10 microM TG for 48 h, cells pre-treated for three days by 10 microM PHE alone (c), or simultaneously with 1 microM PRA (d), followed by 10 microM TG for 48 h. In all cases, TG treatment induces an increase in the percentage of cells in SubG1 phase, thus apoptotic cells (A, a and b; B, a and b; C, a and b). In PHE pre-treatment conditions in DU145 and DUshCTL cells induced a decrease in the percentage of cells in SubG1 phase as compared to TG alone (A, c; B, c). PHE pre-treatment had no effect on the percentage of DUshcav-1 cells in SubG1 phase (C, b and c). The anti-apoptotic effect of PHE was counteracted by PRA in DU145 (A, d) and DUshCTL cells (B, d) where a higher number of apoptotic cells was observed as compared to pretreatment by PHE alone, but this was not observed in Dushcav-1 cells (C, d). It should be noted that PHE (D, 2) or PRA (D, 3) alone had no effect on the cell cycle phases as compared to control DU145 cells (D, 1) (as well as DushCTL and Dushcav-1).
###end p 95
###begin p 96
(0.56 MB PDF)
###end p 96
###begin p 97
Click here for additional data file.
###end p 97
###begin p 98
###xml 372 379 348 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
###xml 1512 1521 1484 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007068-g004">Figure 4A</xref>
Representative examples of Hoechst-stained (A) DU145 wild-type, (B) DUshCTL and (C) DUshcav-1 cells. Cells were (a) non-treated, (b) treated by 10AmicroM TG for 48 h, (c) pre-treated by 10AmicroM PHE for 3 days followed by 48 h 10AmicroM TG or (d) pre-treated simultaneously by 10AmicroM PHE and 1AmicroM PRA for 3 days followed by 48 h 10AmicroM TG (as described in the "Methods" section). Cells fixed in ice-cold methanol (15 min) were stained by 4Amicrog/ml Hoechst 33528 (Sigma) for 30 min. Stained nuclei were observed at 435 nm using a fluorescence microscope (AxioImager, Zeiss). A total of 500 stained nuclei per condition (three slides per condition) were considered and typical apoptotic figures (chromatin condensation and nuclear fragmentation) were counted, indicated here by the white arrowheads. In (A), (B) and (C) we observed a higher level of apoptosis in TG-treated conditions (b) as compared to (a) non-treated conditions. A three day PHE pre-treatment followed by TG induced a lower number of apoptotic cells (A, c) and (B, c) than TG alone (A, b and B, b). This effect was not observed in DUshcav-1 cells (C) where the number of apoptotic cells was almost the same in b, c and d. The anti-apoptotic effect of PHE was counteracted by PRA in DU145 (A, d) and DUshCTL cells (B, d) where a higher number of apoptotic cells was observed as compared to pretreatment by PHE alone. These results are in agreement with our observation of percentage of apoptotic cells in the SubG1 cell cycle phase (Figure 4A, b).
###end p 98
###begin p 99
(2.59 MB TIF)
###end p 99
###begin p 100
Click here for additional data file.
###end p 100
###begin p 101
###xml 77 82 <span type="species:ncbi:9606">human</span>
We are particularly grateful to Pr. Morad Roudbaraki for RNA extraction from human prostate samples and information obtained from the hospital's anatomopathology department. We would also like to thank Dr. Thierry Capiod for his very useful comments and advice on the manuscript.
###end p 101
###begin title 102
References
###end title 102
###begin article-title 103
Global cancer statistics, 2002.
###end article-title 103
###begin article-title 104
Mechanisms involved in the progression of androgen-independent prostate cancers: it is not only the cancer cell's fault.
###end article-title 104
###begin article-title 105
Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance.
###end article-title 105
###begin article-title 106
###xml 65 70 <span type="species:ncbi:9606">human</span>
Studies on the structure and intrinsic innervation of the normal human prostate.
###end article-title 106
###begin article-title 107
###xml 37 42 <span type="species:ncbi:9606">human</span>
Alpha 1-adrenoceptor subtypes in the human prostate.
###end article-title 107
###begin article-title 108
Heterotrimeric G proteins: organizers of transmembrane signals.
###end article-title 108
###begin article-title 109
Non-hormone chemotherapy for prostate cancer: principles of treatment and application to the testing of new drugs.
###end article-title 109
###begin article-title 110
Prostatic alpha 1-adrenoceptors and uroselectivity.
###end article-title 110
###begin article-title 111
Induction of apoptosis in the prostate by alpha1-adrenoceptor antagonists: a novel effect of "old" drugs.
###end article-title 111
###begin article-title 112
Induction of prostate apoptosis by alpha1-adrenoceptor antagonists: mechanistic significance of the quinazoline component.
###end article-title 112
###begin article-title 113
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Oral treatment of the TRAMP mice with doxazosin suppresses prostate tumor growth and metastasis.
###end article-title 113
###begin article-title 114
Alpha1-adrenergic receptors activate Ca(2+)-permeable cationic channels in prostate cancer epithelial cells.
###end article-title 114
###begin article-title 115
Differential role of transient receptor potential channels in Ca2+ entry and proliferation of prostate cancer epithelial cells.
###end article-title 115
###begin article-title 116
G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there?
###end article-title 116
###begin article-title 117
Accumulation of molecules involved in alpha1-adrenergic signal within caveolae: caveolin expression and the development of cardiac hypertrophy.
###end article-title 117
###begin article-title 118
###xml 74 77 <span type="species:ncbi:10116">rat</span>
Alpha1-adrenergic receptor signaling is localized to caveolae in neonatal rat cardiomyocytes.
###end article-title 118
###begin article-title 119
Caveolins, liquid-ordered domains, and signal transduction.
###end article-title 119
###begin article-title 120
The Caveolin genes: from cell biology to medicine.
###end article-title 120
###begin article-title 121
Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.
###end article-title 121
###begin article-title 122
Elevated expression of caveolin is associated with prostate and breast cancer.
###end article-title 122
###begin article-title 123
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells.
###end article-title 123
###begin article-title 124
Caveolin-1, a metastasis-related gene that promotes cell survival in prostate cancer.
###end article-title 124
###begin article-title 125
A simple method for the isolation and purification of total lipides from animal tissues.
###end article-title 125
###begin article-title 126
Quantitative analysis of phospholipids by HPLC with a light scattering evaporating detector: application to raw materials for cosmetic use.
###end article-title 126
###begin article-title 127
###xml 101 109 <span type="species:ncbi:9606">patients</span>
Comparative analysis of plasma and erythrocyte 7-ketocholesterol as a marker for oxidative stress in patients with diabetes mellitus.
###end article-title 127
###begin article-title 128
Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway.
###end article-title 128
###begin article-title 129
A technique for ultracryotomy of cell suspension and tissues.
###end article-title 129
###begin article-title 130
CaV3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells.
###end article-title 130
###begin article-title 131
A role for voltage gated T-type calcium channels in mediating "capacitative" calcium entry?
###end article-title 131
###begin article-title 132
The alpha1a-adrenergic receptor occupies membrane rafts with its G protein effectors but internalizes via clathrin-coated pits.
###end article-title 132
###begin article-title 133
Functions of lipid rafts in biological membranes.
###end article-title 133
###begin article-title 134
Lipid rafts and signal transduction.
###end article-title 134
###begin article-title 135
Lipid rafts have different sizes depending on membrane composition: a time-resolved fluorescence resonance energy transfer study.
###end article-title 135
###begin article-title 136
The size of lipid rafts: an atomic force microscopy study of ganglioside GM1 domains in sphingomyelin/DOPC/cholesterol membranes.
###end article-title 136
###begin article-title 137
Toward understanding the dynamics of membrane-raft-based molecular interactions.
###end article-title 137
###begin article-title 138
The multiple faces of caveolae.
###end article-title 138
###begin article-title 139
Characterization of calcium release-activated apoptosis of LNCaP prostate cancer cells.
###end article-title 139
###begin article-title 140
Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete "sub-G1" peaks on DNA content histograms.
###end article-title 140
###begin article-title 141
Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase.
###end article-title 141
###begin article-title 142
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE.
###end article-title 142
###begin article-title 143
Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant.
###end article-title 143
###begin article-title 144
The BCL-2 protein family: opposing activities that mediate cell death.
###end article-title 144
###begin article-title 145
Bax activation and mitochondrial insertion during apoptosis.
###end article-title 145
###begin article-title 146
Bcl-2 family: life-or-death switch.
###end article-title 146
###begin article-title 147
###xml 49 54 <span type="species:ncbi:9606">human</span>
Localization of the alpha 1A-adrenoceptor in the human prostate.
###end article-title 147
###begin article-title 148
###xml 73 78 <span type="species:ncbi:9606">human</span>
Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue.
###end article-title 148
###begin article-title 149
Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.
###end article-title 149
###begin article-title 150
Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer.
###end article-title 150
###begin article-title 151
Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence.
###end article-title 151
###begin article-title 152
Activation of mitogen-activated protein kinase associated with prostate cancer progression.
###end article-title 152
###begin article-title 153
###xml 55 60 <span type="species:ncbi:9606">human</span>
Activation of extracellular signal-regulated kinase in human prostate cancer.
###end article-title 153
###begin article-title 154
The MEK/ERK cascade: from signaling specificity to diverse functions.
###end article-title 154
###begin article-title 155
Characterization of the alpha1-adrenoceptor subtype activating extracellular signal-regulated kinase in submandibular gland acinar cells.
###end article-title 155
###begin article-title 156
Guanosine phosphate binding protein coupled receptors in prostate cancer: a review.
###end article-title 156
###begin article-title 157
G proteins in cancer: the prostate cancer paradigm.
###end article-title 157
###begin article-title 158
Bradykinin receptor subtype 1 expression and function in prostate cancer.
###end article-title 158
###begin article-title 159
Expression of endothelin receptor a associated with prostate cancer progression.
###end article-title 159
###begin article-title 160
###xml 144 152 <span type="species:ncbi:9606">patients</span>
Quantification of alpha1-adrenoceptor subtypes by real-time RT-PCR and correlation with age and prostate volume in benign prostatic hyperplasia patients.
###end article-title 160
###begin article-title 161
###xml 15 20 <span type="species:ncbi:9606">human</span>
Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
###end article-title 161
###begin article-title 162
Caveolin-1 in tumor progression: the good, the bad and the ugly.
###end article-title 162
###begin article-title 163
The role of caveolin-1 in androgen insensitive prostate cancer.
###end article-title 163
###begin article-title 164
Functional rafts in cell membranes.
###end article-title 164
###begin article-title 165
###xml 82 88 <span type="species:ncbi:10090">murine</span>
Lysophosphatidylcholine-induced surface redistribution regulates signaling of the murine G protein-coupled receptor G2A.
###end article-title 165
###begin article-title 166
Tuning lipid mixtures to induce or suppress domain formation across leaflets of unsupported asymmetric bilayers.
###end article-title 166
###begin article-title 167
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice.
###end article-title 167
###begin article-title 168
De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin.
###end article-title 168
###begin article-title 169
Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction.
###end article-title 169
###begin article-title 170
###xml 107 111 <span type="species:ncbi:10090">mice</span>
The function of alpha- and beta-adrenoceptors of the saphenous artery in caveolin-1 knockout and wild-type mice.
###end article-title 170
###begin article-title 171
The TNM classification of prostate cancer.
###end article-title 171
###begin article-title 172
###xml 30 35 <span type="species:ncbi:9606">human</span>
Noradrenaline contractions of human prostate mediated by alpha 1A-(alpha 1c-) adrenoceptor subtype.
###end article-title 172
###begin article-title 173
alpha1- and alpha2- adrenoceptors in BPH.
###end article-title 173
###begin article-title 174
###xml 112 117 <span type="species:ncbi:9606">human</span>
Epidermal growth factor-induced neuroendocrine differentiation and apoptotic resistance of androgen-independent human prostate cancer cells.
###end article-title 174
###begin article-title 175
###xml 210 213 <span type="species:ncbi:10116">rat</span>
Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts.
###end article-title 175
###begin article-title 176
###xml 14 19 <span type="species:ncbi:9606">human</span>
Comparison of human alpha1-adrenoceptor subtype coupling to protein kinase C activation and related signalling pathways.
###end article-title 176
###begin article-title 177
An alpha1A-adrenergic-extracellular signal-regulated kinase survival signaling pathway in cardiac myocytes.
###end article-title 177
###begin p 178
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 178
###begin p 179
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the French Ministry of Research and the University of Lille 1, INSERM and the Region Nord-Pas de Calais as well as the Ligue Nationale Contre le Cancer (Comite du Nord) and the Association pour la Recherche sur le Cancer (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 179

